微RNA-它们是否可能是过敏疾病和有效免疫治疗的标记物?
Krzysztof Specjalski1, Marek Niedoszytko1
1Department of Allergology, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
International journal of molecular sciences
|January 28, 2026
概括
微RNAs (miRNAs) 是过敏疾病的关键调节者,并显示出作为诊断和监测的非侵入性生物标志物的潜力. 虽然对免疫疗法和治疗有希望,但在分娩和安全方面的挑战阻碍了临床翻译.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 微RNA (miRNA) 是简短的,非编码的RNA分子,可以调节基因表达.
- 新出现的证据突出了它们在过敏疾病的发病过程中的重要作用,影响了免疫反应和上皮功能.
研究的目的:
- 审查miRNAs在过敏性疾病 (过敏性鼻炎,喘,皮炎) 中的作用.
- 探索miRNAs作为用于诊断,严重性评估和内型鉴定的非侵入性生物标志物的潜力.
- 评估miRNAs在过敏原免疫治疗中的意义及其作为治疗点的潜力.
主要方法:
- 对调查miRNA参与过敏疾病的研究进行文献综述.
- 分析与疾病诊断,严重程度和免疫治疗结果相关的miRNA表达特征.
- 检查miRNAs在免疫调节和耐受性诱导中的机制性作用.
主要成果:
- 特定的miRNA与过敏性鼻炎,喘和亚托邦性皮肤炎有关,这表明生物标志物的潜力.
- 在过敏原免疫疗法期间,miRNA配置文件发生变化,与耐受性诱导相关 (例如,Treg细胞活性,IL-10,TGF-β产生).
- miRNAs被认为是潜在的治疗点,正在探索对抗体.
结论:
- miRNAs是过敏疾病的有希望的非侵入性生物标志物,也是成功免疫治疗的指标.
- 尽管体外和动物模型的成功,但在交付,向和安全方面存在重大障碍,阻碍了基于miRNA的疗法转化为人类临床应用.
更多相关视频
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
8.1K
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
8.7K
相关概念视频
02:06Allergic Reactions
32.3K
Overview
32.3K
01:22MicroRNAs
24.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.2K
01:22MicroRNAs
4.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.0K
01:27Tumor Immunotherapy
1.9K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
01:27Allergic Drug Reactions
1.5K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K
01:01Production Efficiency
18.3K
Net production efficiency (NPE) is the efficiency at which organisms assimilate energy into biomass for the next trophic level. Due to low metabolic rates and less energy spent on thermoregulatory processes, the NPE of ectotherms (cold-blooded animals) is 10 times higher than endotherms (warm-blooded animals).
18.3K